SO
APGE

STRS Ohio’s Apogee Therapeutics APGE Stock Holding History

STRS Ohio’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
8,500
+4,100
+93% +$369K ﹤0.01% 682
2026
Q1 		$370K Buy
4,400
+1,100
+33% +$79.9K ﹤0.01% 1237
2025
Q4 		$249K Buy
+3,300
New +$208K ﹤0.01% 1421
2025
Q1 		– Sell
-5,500
Closed -$249K – 1933
2024
Q4 		$249K Sell
5,500
-600
-10% -$30.6K ﹤0.01% 1430
2024
Q3 		$358K Hold
6,100
– – ﹤0.01% 1392
2024
Q2 		$240K Buy
6,100
+2,200
+56% +$107K ﹤0.01% 1513
2024
Q1 		$259K Sell
3,900
-200
-5% -$8.73K ﹤0.01% 1484
2023
Q4 		$114K Hold
4,100
– – ﹤0.01% 1674
2023
Q3 		$87K Buy
+4,100
New +$90.3K ﹤0.01% 1735

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

STRS Ohio's APGE Position: Q2 2026 in Review

STRS Ohio increased its Apogee Therapeutics (APGE) stake by 93% in Q2 2026, buying an estimated $369K and bringing the position to 8,500 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #682.

STRS Ohio first reported a position in APGE in Q3 2023 and has held it in 9 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • STRS Ohio held 8,500 shares of Apogee Therapeutics worth $1.13M as of Q2 2026.
  • STRS Ohio bought 4,100 Apogee Therapeutics shares in Q2 2026, an estimated $369K.
  • Apogee Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #682 holding.
  • STRS Ohio first reported a position in Apogee Therapeutics in Q3 2023 and has held it in 9 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.